EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieRandomisierte kontrollierte Studie

Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?

David J Maron

Nature Clinical Practice Cardiovascular Medicine · 2004

DOI: 10.1038/ncpcardio0006 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2004. Verfasst von David J Maron. Beteiligte Einrichtung: Kim Dayani Center for Health Promotion at Vanderbilt University, Nashville, TN, USA. david.maron@vanderbilt.edu. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute DiseaseAdultAnticholesteremic AgentsCholesterol, HDLCholesterol, LDLFemaleFollow-Up StudiesHumansIncidenceMaleMyocardial IschemiaPravastatinRisk FactorsSurvival RateTreatment Outcome

Substanzen

Anticholesteremic AgentsCholesterol, HDLCholesterol, LDLPravastatin

Autor:innen und Institutionen

  • Kim Dayani Center for Health Promotion at Vanderbilt University, Nashville, TN, USA. david.maron@vanderbilt.edu

Zitieren

APA

Maron, D. J. (2004). Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0006

Vancouver

Maron DJ. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?. Nature Clinical Practice Cardiovascular Medicine. 2004. doi:10.1038/ncpcardio0006

BibTeX
@article{Maron2004,
  author = {Maron, David J},
  title = {Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?},
  journal = {Nature Clinical Practice Cardiovascular Medicine},
  year = {2004},
  doi = {10.1038/ncpcardio0006}
}
Kostenlos starten →